Mendlein John's Form 4 filing
Fate Therapeutics Inc (FATE) · filed Mar 11, 2022
- Accession no.
- 0001209191-22-018188
- Filed
- Mar 11, 2022
- Trade date
- Mar 10, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.11M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mendlein JohnCIK 0001238362 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2022 | Common Stock | MOption exerciseAcquired | +31,562 | $1.63 | +$51,446.06 | 191,017 | Direct | |
| Mar 10, 2022 | Common Stock | SSaleDisposed | −19,493 | $34.73 | −$676,991.89 | 171,524 | Direct | |
| Mar 10, 2022 | Common Stock | SSaleDisposed | −12,069 | $35.48 | −$428,208.12 | 159,455 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2022 | Common Stock | MOption exerciseDisposed | −31,562 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.